ALEXANDRIA, Va., May 5 -- United States Patent no. RE50,880, issued on May 5, was assigned to Kymab Ltd. (Cambridge, Great Britain).
"Anti-human OX40L antibodies and methods of treatment" was invented by Jamie Campbell (Cambridge, Great Britain), Steve Holmes (Cambridge, Great Britain), Ian Kirby (Cambridge, Great Britain) and Miha Kosmac (Cambridge, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to anti-human OX40L antibodies, new medical uses and methods."
The patent was filed on Aug. 1, 2022, under Application No. 17/816,698.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=...